Karen Koski analyst

Currently out of the existing stock ratings of Karen Koski, 6 are a HOLD (60%), 1 are a SELL (10%), 3 are a BUY (30%).

Karen Koski

Work Performance Price Targets & Ratings Chart

Analyst Karen Koski, currently employed carries an average stock price target met ratio of 83.33% that have a potential upside of 30.31% achieved within 193 days.

Karen Koski’s has documented 15 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on AXDX, Accelerate Diagnostics at 08-Oct-2020.

Wall Street Analyst Karen Koski

Analyst best performing recommendations are on AXDX (ACCELERATE DIAGNOSTICS).
The best stock recommendation documented was for AXDX (ACCELERATE DIAGNOSTICS) at 8/9/2016. The price target of $260 was fulfilled within 36 days with a profit of $40 (18.18%) receiving and performance score of 5.05.

Average potential price target upside

TTOO T2 Biosystms AXDX Accelerate Diagnostics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$5

$3.18 (174.73%)

$3

2 months 5 days ago

6/6 (100%)

$0.11 (2.25%)

16

Hold

1 years 1 months 20 days ago

3/4 (75%)

$-3.75 (-34.88%)

38

Hold

$7500

2 years 2 months 28 days ago

3/5 (60%)

$3649 (94.75%)

390

Buy

$15000

3 years 11 months ago

1/1 (100%)

$7050 (88.68%)

177

Hold

$200

$194.55 (3569.72%)

$200

7 years 4 months 27 days ago

2/3 (66.67%)

$64.67 (8.94%)

172

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Karen Koski?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?